Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. discloses novel orexin receptor antagonists for insomnia

Jan. 15, 2009

New gamma-secretase modulators reported in recent Schering-Plough patent

Jan. 15, 2009

Santen describes novel glucocorticoid receptor ligands for metabolic disorders, among others

Jan. 15, 2009

New Chlamydia vaccine patented by the Thrombosis Research Institute

Jan. 14, 2009

Recent Merck & Co. patent discloses a new series of polypeptides with antibacterial properties

Jan. 14, 2009

GSK reports novel AMPA receptor modulators with antipsychotic properties

Jan. 14, 2009

New humaneered anti-factor B antibodies reported in recent Taligen patent

Jan. 14, 2009

ZymoGenetics divulges novel antipsoriatic ztnfr14 antagonists

Jan. 14, 2009

Novel mGluR2 metabotropic glutamate receptor agonists disclosed by AstraZeneca

Jan. 13, 2009

OncoMed imparts novel anti-Jagged 1 monoclonal antibodies with anticancer properties

Jan. 13, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...